Atlas Trials

Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets

Clinical trial NCT07681544 · COMPLETED

Trial details

NCT number
NCT07681544
Sponsor
Hospital Italiano de Buenos Aires
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Empirical Antimicrobial TherapyCritically IllMeropenemPharmacokinetics and Pharmacodynamics
Start date
2024-06-26
Primary completion
2024-09-20
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.